Biobank Cycle Collection (BCC)

Biobank Cycle Collection Study From Women Trying to Conceive

This study will provide daily urine samples from volunteers who are trying to conceive in order to maintain the SPD biobank.

Study volunteers, seeking to conceive will be provided with a CE marked Clearblue Ovulation product to help them pinpoint their most fertile time and aid conception. All volunteers will provide daily early morning urine samples throughout the study period and keep a study diary of menses and pregnancy test results for up to 3 menstrual cycles.

Urine samples will be received in the clinical laboratory and aliquoted and stored at -80˚C until required.

Study Overview

• Status: Recruiting
• Conditions: Pregnancy

Detailed Description

The purpose if this study is to maintain the SPD Biobank with urine samples from cycles in which conception occurred and ones where conception did not occur, together with associated sample information including demographic and clinical data e.g. menses days, volunteer age and reproductive hormone concentrations.

Study volunteers, seeking to conceive will be recruited to the study after providing written informed consent. All volunteers will be provided with a CE marked Clearblue Ovulation product to help them pinpoint their most fertile time and aid conception and be required to collect daily early morning urine samples throughout the study until pregnancy is confirmed or their next menstrual period starts. Volunteers will be required to keep a daily diary of menses, sample collection and pregnancy test results. The study will last for up to 3 consecutive menstrual cycles if not pregnant and up to sample day 60 if pregnant.

Urine samples will be received in the clinical laboratory and will be tested for the presence of hormones related to pregnancy and fertility, then aliquoted and stored in the SPD Biobank at -80˚C until required for product development or evaluation purposes.

• Study Type: Observational
• Enrollment (Estimated): 1500

Contacts and Locations

• Study Contact: Name: Sarah Weddell; Phone Number: 35162 01234 835000; Email: sarah.weddell@spdspark.com
• Study Contact Backup: Name: Sharon Bond; Phone Number: 35524 01234 835000; Email: sharon.bond@spdspark.com

Study Locations

• United Kingdom
  • Bedfordshire
    • Bedford, Bedfordshire, United Kingdom, MK44 3UP
      • Recruiting
      • SPD Development Company Ltd
      • Contact: Sarah Weddell; Phone Number: 01234835000; Email: sarah.weddell@spdspark.com
      • Contact: Jackie Boxer; Phone Number: 01234835000; Email: jackie.boxer@spdspark.com
      • Principal Investigator: Jackie Boxer

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes

• Sampling Method: Non-Probability Sample

Study Population

Women trying to conceive

Description

Inclusion Criteria:

• Females aged 18 and over actively trying to conceive
• At least 2 regular consecutive cycles since last pregnancy/miscarriage/ stopping breastfeeding or contraception
• Willing to disclose their pregnancy status and provide urine samples.
• Willing to give informed consent and comply with the study procedures

Exclusion Criteria:

• Trying to conceive for >6 months (under 35 years) or > 3 months (35 years and over)
• Has a diagnosis of Polycystic Ovary Syndrome (PCOS)
• Taking medication or has known condition which means they should not get pregnant.
• Currently pregnant or breastfeeding
• Using any treatment which may affect the menstrual cycle (e.g. contraceptive pill)
• Using or has previously used infertility medications or hormone replacement medications containing LH or hCG \ (e.g. Pregnyl®)
• Using or undergoing any other medical treatment for fertility such as ovulation drugs, artificial insemination and assisted fertility such as IVF or ICSI
• Peri-or post-menopausal, e.g. experiencing symptoms: irregular menstrual periods, hot flushes, night sweats, sleep disturbances and/or moods swings
• Abnormal liver or kidney function
• Taking antibiotics containing tetracycline.
• Participated in this study within the last 6 months

Study Plan

How is the study designed?

Design Details

• Observational Models: Cohort
• Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Collection of daily urine samples from women trying to conceive	Daily samples collected throughout the cycle in which conception occurs	From recruitment until sample collection complete (up to 3 menstrual cycles if not pregnant and sample day 60 if pregnant)

Collaborators and Investigators

• Sponsor: SPD Development Company Limited
• Investigators: Study Director: Raniero Zazzeroni, SPD Development Company

Study record dates

Study Major Dates

• Study Start (Actual): December 6, 2022
• Primary Completion (Estimated): January 1, 2028
• Study Completion (Estimated): January 1, 2028

Study Registration Dates

• First Submitted: November 30, 2022
• First Submitted That Met QC Criteria: November 30, 2022
• First Posted (Actual): December 8, 2022

Study Record Updates

• Last Update Posted (Actual): April 17, 2026
• Last Update Submitted That Met QC Criteria: April 14, 2026
• Last Verified: April 1, 2026

More Information

Terms related to this study

• Keywords: Fertility; Trying to Conceive
• Other Study ID Numbers: PROTOCOL-1388

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No